• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gossamer Bio, Inc. - Common Stock (NQ:GOSS)

0.1701 -0.0038 (-2.19%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Gossamer Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Friday's session: most active stocks ↗
August 21, 2026
Via Chartmill
Which stocks are moving before the opening bell on Friday? ↗
August 21, 2026
Via Chartmill
News headline image
Gossamer Bio Announces Up to $250 Million Structured Private Placement, Including $150 Million of Committed Capital, to Fund Seralutinib Through Potential FDA Approval
August 21, 2026
From Gossamer Bio, Inc.
Via Business Wire
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
August 14, 2026
Via Chartmill
News headline image
Gossamer Bio Announces Second Quarter 2026 Financial Results and Provides Business Update
August 13, 2026
From Gossamer Bio, Inc.
Via Business Wire
Check out the stocks that are attracting the most attention and driving market activity. ↗
July 28, 2026
Via Chartmill
News headline image
Undervalued Stocks in Focus: IGC, CISS, TOON, GOSS, KIDZ Enter Catalyst-Rich Growth Phase
July 28, 2026
Via AB Newswire
Topics Artificial Intelligence
Which stocks are moving before the opening bell on Tuesday? ↗
July 28, 2026
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
July 28, 2026
Gainers Gossamer Bio (NASDAQ:GOSS) shares moved upwards by 47.2% to $0.29 during Tuesday's pre-market session. The company's market cap stands at $97.4 million. Prelude Therapeutics (NASDAQ:PRLD)... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
July 27, 2026
Gainers Gossamer Bio (NASDAQ:GOSS) shares rose 28.8% to $0.26 during Monday's after-market session. The company's market cap stands at $66.4 million. ProMIS Neurosciences (NASDAQ:PMN) shares increased... 
Via Benzinga
Top movers in Monday's after hours session ↗
July 27, 2026
Via Chartmill
Which stocks are moving on Monday? ↗
July 27, 2026
Via Chartmill
Curious about the most active stocks on Monday? ↗
July 27, 2026
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
July 27, 2026
Gainers Entera Bio (NASDAQ:ENTX) stock moved upwards by 86.6% to $3.83 during Monday's regular session. The company's market cap stands at $100.9 million. Gossamer Bio (NASDAQ:GOSS) shares moved... 
Via Benzinga
Monday's session: top gainers and losers ↗
July 27, 2026
Via Chartmill
These stocks that are showing activity before the opening bell on Monday. ↗
July 27, 2026
Via Chartmill
News headline image
Gossamer Bio Announces FDA Regulatory Update and Reacquisition of Worldwide Rights Related to Seralutinib and Provides a Business Update
July 27, 2026
From Gossamer Bio, Inc.
Via Business Wire
Top movers in Monday's after hours session ↗
July 20, 2026
Via Chartmill
News headline image
Gossamer Bio, Inc. Announces Determination of Conversion Rate for 7.50% Convertible Senior Secured First Lien Notes due 2030 and Exercise Price for Purchase Warrants
July 01, 2026
From Gossamer Bio, Inc.
Via Business Wire
Wondering what's happening in today's after-hours session? ↗
June 29, 2026
Via Chartmill
News headline image
Gossamer Bio, Inc. Announces Final Tender Results for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes
June 17, 2026
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Gossamer Bio, Inc. Announces Early Tender Results and Early Settlement for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes
June 03, 2026
From Gossamer Bio, Inc.
Via Business Wire
News headline image
CLASS ACTION DEADLINE TONIGHT: Gossamer Bio (GOSS) Investors Who Suffered Losses Encouraged to Contact Faruqi & Faruqi Before June 1, 2026 Securities Class Action Deadline
June 01, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
June 01, 2026
From The Schall Law Firm
Via Business Wire
News headline image
Gossamer Bio, Inc. Announces Extension of Early Tender Date for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes
June 02, 2026
From Gossamer Bio, Inc.
Via Business Wire
News headline image
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
May 31, 2026
From Schall Law
Via GlobeNewswire
News headline image
GOSSAMER BIO DEADLINE MONDAY JUNE 1st: Bragar Eagel & Squire, P.C. Urges Gossamer Bio, Inc. (NASDAQ:GOSS) Investors with Large Losses to Contact the Firm Before Monday June 1st
May 29, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Deadline Soon: Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
May 29, 2026
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
May 28, 2026
From Schall Law
Via GlobeNewswire
News headline image
GOSSAMER DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – GOSS
May 27, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap